MedTrace Logo

A Non-interventional, Observational Study for Targinact® Treatment in Patients With Chronic Severe Pain

NCT01710904 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 68

Last updated 2015-04-08

No results posted yet for this study

Summary

This non-interventional, observational study is set up on request of the Belgian reimbursement authorities and evaluates the efficacy of Targinact with regard to pain relief and constipation in daily clinical practice in Belgium compared to the previous analgesic treatment with prolonged release oxycodone. Only patients eligible for Targinact® reimbursement in Belgium are included.

Conditions

  • Chronic Severe Pain

Interventions

DRUG

Targinact® (oxycodone/naloxone)

Sponsors & Collaborators

  • Mundipharma CVA

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2013-07-31
Completion
2014-01-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01710904 on ClinicalTrials.gov